For occasional use when all other antimicrobials have proved ineffective
pneumonia; complicated skin and soft-tissue infections caused by Gram-positive bacteria
Clostridium difficile infection; Streptococcal or enterococcal endocarditis; Bone and joint infections
Red drug when used for Cystic fibrosis indications only
Hospital-acquired pneumonia, septicaemia, complicated intra-abdominal infections, complicated infections involving the urinary tract or skin and soft tissues; Infections in neutropenic patients
Primaxim
Aerobic and anaerobic infections; hospital-acquired septicaemia
Aerobic and anaerobic Gram-positive and Gram-negative infections; hospital-acquired septicaemia
For occasional use when all other antimicrobials have proved ineffective. Use must be authorised by an infectious disease consultant
SF susp - 125mg/5ml, 250mg/5ml
Capsules - 500mg
Capsules - 250mg - Only this dose if higher dose not tolerated or clinical reasons
Susp - 125mg/5ml, 250mg/5ml - For UTI in Children
Susp - 500mg - UTI in pregnancy
Tablets - 250mg, 500mg
Suspension - 250mg/5ml
For pyelonephritis, acute prostatitis
Capsules - 150mg
For unresolving cellulitis, severe dental infection
Tablets - 375mg, 625mg - For persistent sinusitis, COPD where RF for resistance, pyelonephritis, human or animal bites, facial cellulitis
SF Susp- 125/31, 250/62, 400/57 - for upper UTI in children
SF Susp - 125mg/5ml, 250mg/5ml - for under 12's where penicillin allergy
Tablets 250mg - only where pregnant and penicillin allergy
Capsules - 250mg(only where lower dose is clinically indicated), 500mg
Soln - 125mg/5ml, 250mg/5ml
SF Soln - 125mg/5ml, 250mg/5ml
Tablets - 200mg, 400mg Lower dose where clinically indicated
Susp - 200mg/5ml
Tablets - 550mg
Initiated by Consultant microbiologist or consultant gastroenterologist only in line with NICE TA 337 Rifaximin for preventing episodes of overt hepatic encephalopathy as an option for reducing the recurrence of episodes of overt hepatic encephalopathy in people aged 18 years or older.
Injections and tablets
For use by consultants in infectious disease. In cases of "fluconazole resistance"
Fungal infections
Invasive candidiasis in paediatrics
Invasive candidiasis/aspergillosis
Medication for malaria prophylaxis is not reimbursible by the NHS.
Prescription only medicines for malaria prophylaxis should be prescribed privately and other medications can be purchased via a local community pharmacy.
Useful prescribing information - a guide for prescribers (51 downloads)
Wuchereria bancrofti infections; brugia malayi infections; loa loa infections
Unlicensed Oral formulations
Chronic strongyloides infection; cutaneous larva migrans; scabies
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation
Patient Group Directions - NECS Medicines Optimisation